Showing 1 - 18 results of 18 for search '(( 30 c decrease ) OR ( 10 ((mean decrease) OR (((_ decrease) OR (a decrease)))) ))~', query time: 0.22s Refine Results
  1. 1
  2. 2
  3. 3

    Preparation and characterization of wollastonite/titanium oxide nanofiber bioceramic composite as a future implant material by Aly, Ibrahim H.M.

    Published 2016
    “…Typically, TiO2/wollastonite composites having 0, 10, 20 and 30wt% metal oxide nanofibers were sintered at 900, 1100 and 1250°C. …”
    Get full text
    Get full text
    Get full text
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    CLINICAL AND ECONOMIC IMPACT OF GENETIC AND NON-GENETIC FACTORS ON INR NORMALIZATION IN PRE-OPERATIVE MANAGEMENT OF WARFARIN PATIENTS by ELJILANY, ISLAM AHMED SAYED AHMED

    Published 2021
    “…To optimize the period of preprocedural warfarin interruption to decrease the incidence of bleeding in case of bridging and the incidence of thromboembolism in case of non-bridging, a study was conducted to determine the influence of CYP2C9, VKORC1, CYP4F2, FII, and FVII genetic polymorphisms and non-genetic factors on INR decline in a cohort of Arabs undergoing a procedure that requires warfarin interruption and developing an algorithm to tailor the duration of warfarin interruption before the procedure. …”
    Get full text
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Exploring Beyond Numeric Weight Loss: The Metabolic Effects of Semaglutide. by Sara, Sokary

    Published 2025
    “…Also, it enhanced glycemic control, as evidenced by significant reductions in hemoglobin A1C (HbA1c) with the 0.5 mg and 1.0 mg doses. From a baseline range of 8.1–8.7%, 0.5mg dose lowered HbA1c by 1.2–1.5%, while the 1.0 mg dose reduced it by 1.4–1.8%. …”
    Get full text
    Get full text
    Get full text
    article
  15. 15
  16. 16
  17. 17
  18. 18